hydroxyurea has been researched along with Peripheral Nerve Diseases in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Factors affecting patient adherence to therapy, such as frequent daily dosing and complex dosing schedules, are widely understood to be key obstacles to the durability of effective anti-HIV therapy." | 2.41 | Didanosine once daily: potential for expanded use. ( Pollard, RB, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moore, RD | 1 |
| Wong, WM | 1 |
| Keruly, JC | 1 |
| McArthur, JC | 1 |
| Cepeda, JA | 1 |
| Wilks, D | 1 |
| Rutschmann, OT | 1 |
| Vernazza, PL | 1 |
| Bucher, HC | 1 |
| Opravil, M | 1 |
| Ledergerber, B | 1 |
| Telenti, A | 1 |
| Malinverni, R | 1 |
| Bernasconi, E | 1 |
| Fagard, C | 1 |
| Leduc, D | 1 |
| Perrin, L | 1 |
| Hirschel, B | 1 |
| Pollard, RB | 1 |
1 review available for hydroxyurea and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Didanosine once daily: potential for expanded use.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; Liver; | 2000 |
1 trial available for hydroxyurea and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study.
Topics: Anti-HIV Agents; Diarrhea; Didanosine; Drug Therapy, Combination; Enzyme Inhibitors; Follow-Up Studi | 2000 |
2 other studies available for hydroxyurea and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea.
Topics: Adult; Aged; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; | 2000 |
Excess peripheral neuropathy in patients treated with hydroxyurea plus didanosine and stavudine for HIV infection.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; Periphe | 2000 |